Aspex Management (HK)’s Teradyne TER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$150M Sell
506,070
-525,768
-51% -$147M 2.17% 14
2025
Q4
$200M Buy
+1,031,838
New +$177M 4.04% 11
2025
Q1
Sell
-3,234,842
Closed -$407M 36
2024
Q4
$407M Buy
3,234,842
+847,409
+35% +$100M 11.01% 3
2024
Q3
$320M Buy
2,387,433
+246,914
+12% +$33.3M 8.47% 4
2024
Q2
$317M Buy
2,140,519
+380,885
+22% +$48.4M 6.78% 2
2024
Q1
$199M Buy
+1,759,634
New +$183M 5.31% 8

Other funds holding TER

Aspex Management (HK)'s TER Position: Q1 2026 in Review

Aspex Management (HK) reduced its Teradyne (TER) stake by 51% in Q1 2026, selling an estimated $147M and leaving 506,070 shares worth $150M. The position accounts for 2.17% of the portfolio, ranked #14.

Aspex Management (HK) first reported a position in TER in Q1 2024 and has held it in 6 quarters since. The position peaked at $407M in Q4 2024. 1,223 funds tracked by Wall St. Rank hold TER as of Q1 2026.

  • Aspex Management (HK) held 506,070 shares of Teradyne worth $150M as of Q1 2026.
  • Aspex Management (HK) sold 525,768 Teradyne shares in Q1 2026, an estimated $147M.
  • Teradyne made up 2.17% of Aspex Management (HK)'s portfolio in Q1 2026, its #14 holding.
  • Aspex Management (HK) first reported a position in Teradyne in Q1 2024 and has held it in 6 quarters since.
  • Aspex Management (HK)'s Teradyne position peaked at $407M in Q4 2024.
  • 1,223 funds tracked by Wall St. Rank held Teradyne as of Q1 2026.

Based on Aspex Management (HK)'s 13F filing for Q1 2026, filed 15 May 2026.